Supreme Court temporarily lifts telehealth ban on abortion drug mifepristone - MSN
The Supreme Court temporarily lifted restrictions on telehealth prescribing of mifepristone, allowing remote prescribing to continue pending further litigation.
Aforeworn detected this change in the Telehealth Cross-State Licensing space on July 7, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Telehealth platforms, virtual specialty clinics, behavioral-health providers, e-prescribers should confirm how it applies to their specific situation before acting. There is a time constraint attached: Ongoing; no immediate deadline but stay may be lifted upon further court order.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Telehealth Cross-State Licensing continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The Supreme Court issued a temporary stay on lower court rulings that would have reinstated in-person dispensing requirements for mifepristone, thereby preserving current telehealth access to the drug.
Who it affects
Telehealth platforms, virtual specialty clinics, behavioral-health providers, e-prescribers
What you must do
Continue to comply with existing FDA Risk Evaluation and Mitigation Strategy (REMS) requirements for mifepristone, including certification and patient agreement forms, while monitoring for further court decisions.
Deadline
Ongoing; no immediate deadline but stay may be lifted upon further court order.
Never miss a change like this again
Aforeworn watches Telehealth Cross-State Licensing around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Telehealth Cross-State Licensing
- Ohio lawmakers loosen veterinary telemedicine rule - VIN News Service
- DEA Final Rule Takes Effect for EMS Controlled Substances - Michigan Health & Hospital Association
- FDA Proposes Rule That Would Help Hold Foreign Tobacco Product Manufacturers Accountable, Protect Public Health
- DEA extends telemedicine option for prescribing controlled medications - BenefitsPRO
- DEA Releases Proposed Rules Regarding Telemedicine Prescribing of Controlled Substances - - Manatt, Phelps & Phillips, LLP